Cardiotrophin 1 is involved in cardiac, vascular, and renal fibrosis and dysfunction

Hypertension

Volumn 60, Issue 2, 2012, Pages 563-573

  López Andrés, Natalia ^a   Rousseau, Amélie ^a   Akhtar, Riaz ^b   Calvier, Laurent ^a   Iñigo, Carmen ^c   Labat, Carlos ^a   Zhao, Xuegen ^e   Cruickshank, Kennedy ^f   Díez, Javier ^c,d   Zannad, Faiez ^a   Lacolley, Patrick ^a   Rossignol, Patrick ^a  

^a INSERM   (France)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c Centre for Applied Medical Research   (Spain)

^d UNIVERSITY CLINIC OF NAVARRA   (Spain)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

arterial stiffness; cardiotrophin 1; fibrosis; renal dysfunction; ventricular function

Indexed keywords

CARDIOTROPHIN 1; COLLAGEN; CREATININE; FIBRONECTIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE FIBROSIS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY FIBROSIS; KIDNEY FUNCTION; MICROALBUMINURIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; WALL STRESS; WESTERN BLOTTING;

ANIMALS; BLOOD VESSELS; CARDIOVASCULAR SYSTEM; CREATININE; CYTOKINES; FIBROSIS; HEART; HEART VENTRICLES; KIDNEY; MALE; MODELS, ANIMAL; MYOCARDIUM; RATS; RATS, WISTAR; STROKE VOLUME; VASCULAR STIFFNESS;

EID: 84864278283     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.194407     Document Type: Conference Paper

References (31)

1. Shirwany NA, Zou MH. Arterial stiffness: A brief review. Acta Pharmacol Sin. 2010;31:1267-1276.
2. Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, Krumholz HM. Renal impairment and outcomes in heart failure: systematic review and meta-Analysis. J Am Coll Cardiol. 2006; 47:1987-1996.
3. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. 1999;79:215-262. (Pubitemid 29056953)
4. Creemers EE, Pinto YM. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res. 2011;89: 265-272.
5. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension. 2001;38:581-587.
6. Lacolley P, Challande P, Osborne-Pellegrin M, Regnault V. Genetics and pathophysiology of arterial stiffness. Cardiovasc Res. 2009;81:637-648.
7. Harris RC, Neilson EG. Toward a unified theory of renal progression. Annu Rev Med. 2006;57:365-380. (Pubitemid 43261996)
8. Labban B, Arora N, Restaino S, Markowitz G, Valeri A, Radhakrishnan J. The role of kidney biopsy in heart transplant candidates with kidney disease. Transplantation. 2010;89:887-893.
9. Pennica D, King KL, Shaw KJ, Luis E, Rullamas J, Luoh SM, Darbonne WC, Knutzon DS, Yen R, Chien KR, Baker JB, Wood WI. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci U S A. 1995;92:1142-1146.
10. Gonzalez A, Lopez B, Martin-Raymondi D, Lozano E, Varo N, Barba J, Serrano M, Diez J. Usefulness of plasma cardiotrophin-1 in assessment of left ventricular hypertrophy regression in hypertensive patients. J Hypertens. 2005;23:2297-2304. (Pubitemid 41666760)
11. Lopez B, Gonzalez A, Querejeta R, Barba J, Diez J. Association of plasma cardiotrophin-1 with stage C heart failure in hypertensive patients: potential diagnostic implications. J Hypertens. 2009;27: 418-424.
12. Talwar S, Squire IB, Downie PF, O'Brien RJ, Davies JE, Ng LL. Elevated circulating cardiotrophin-1 in heart failure: relationship with parameters of left ventricular systolic dysfunction. Clin Sci (Lond). 2000; 99:83-88. (Pubitemid 30479396)
13. Jin H, Yang R, Keller GA, Ryan A, Ko A, Finkle D, Swanson TA, Li W, Pennica D, Wood WI, Paoni NF. In vivo effects of cardiotrophin-1. Cytokine. 1996;8:920-926. (Pubitemid 27091193)
14. Lopez N, Diez J, Fortuno MA. Differential hypertrophic effects of cardiotrophin-1 on adult cardiomyocytes from normotensive and spontaneously hypertensive rats. J Mol Cell Cardiol. 2006;41:902-913. (Pubitemid 44635572)
15. Lopez-Andres N, Fortuno MA, Diez J, Zannad F, Lacolley P, Rossignol P. Vascular effects of cardiotrophin-1: A role in hypertension? J Hypertens. 2010;28:1261-1272.
16. Tsuruda T, Jougasaki M, Boerrigter G, Huntley BK, Chen HH, D'Assoro AB, Lee SC, Larsen AM, Cataliotti A, Burnett JC Jr. Cardiotrophin-1 stimulation of cardiac fibroblast growth: roles for glycoprotein 130/leukemia inhibitory factor receptor and the endothelin type A receptor. Circ Res. 2002;90:128-134. (Pubitemid 34627080)
17. Ishikawa M, Saito Y, Miyamoto Y, Harada M, Kuwahara K, Ogawa E, Nakagawa O, Hamanaka I, Kajiyama N, Takahashi N, Masuda I, Hashimoto T, Sakai O, Hosoya T, Nakao K. A heart-specific increase in cardiotrophin-1 gene expression precedes the establishment of ventricular hypertrophy in genetically hypertensive rats. J Hypertens. 1999;17: 807-816. (Pubitemid 29322168)
18. Lopez-Andres N, Martin-Fernandez B, Rossignol P, Zannad F, Lahera V, Fortuno MA, Cachofeiro V, Diez J. A Role for cardiotrophin-1 in myocardial remodelling induced by aldosterone. Am J Physiol Heart Circ Physiol. 2011;301:H2372-H2382.
19. Agbulut O, Coirault C, Niederlander N, Huet A, Vicart P, Hagege A, Puceat M, Menasche P. GFP expression in muscle cells impairs actinmyosin interactions: implications for cell therapy. Nat Methods. 2006; 3:331.
20. Lacolley P, Labat C, Pujol A, Delcayre C, Benetos A, Safar M. Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone. Circulation. 2002;106:2848-2853. (Pubitemid 35396986)
21. Zhao X, Akhtar R, Nijenhuis N, Wilkinson SJ, Murphy L, Ballestrem C, Sherratt MJ, Watson REB, Derby B. Multi-layer phase analysis: quantifying the elastic properties of soft tissues and live cells with ultra-highfrequency scanning acoustic microscopy. IEEE Trans Ultrason Ferroelectr Freq Control. 2012;59:610-620.
22. Akhtar R, Sherratt MJ, Watson RE, Kundu T, Derby B. Mapping the micromechanical properties of cryo-sectioned aortic tissue with scanning acoustic microscopy. Mater Res Soc Symp Proc. 2009;1132E(1132-Z03-07): ukpmcpa27262.
23. Graham HK, Akhtar R, Kridiotis C, Derby B, Kundu T, Trafford AW, Sherratt MJ. Localised micro-mechanical stiffening in the ageing aorta. Mech Ageing Dev. 2011;132:459-467.
24. Qin W, Chung AC, Huang XR, Meng XM, Hui DS, Yu CM, Sung JJ, Lan HY. TGF-/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol. 2011;22:1462-1474.
25. Cottone S, Nardi E, Mule G, Vadala A, Lorito MC, Riccobene R, Palermo A, Arsena R, Guarneri M, Cerasola G. Association between biomarkers of inflammation and left ventricular hypertrophy in moderate chronic kidney disease. Clin Nephrol. 2007;67:209-216. (Pubitemid 46605370)
26. Lopez N, Varo N, Diez J, Fortuno MA. Loss of myocardial LIF receptor in experimental heart failure reduces cardiotrophin-1 cytoprotection: A role for neurohumoral agonists? Cardiovasc Res. 2007; 75:536-545. (Pubitemid 47080972)
27. Zolk O, Engmann S, Munzel F, Krajcik R. Chronic cardiotrophin-1 stimulation impairs contractile function in reconstituted heart tissue. Am J Physiol Endocrinol Metab. 2005;288:E1214-E1221. (Pubitemid 40726809)
28. Bezie Y, Lacolley P, Laurent S, Gabella G. Connection of smooth muscle cells to elastic lamellae in aorta of spontaneously hypertensive rats. Hypertension. 1998;32:166-169. (Pubitemid 28324143)
29. Intengan HD, Thibault G, Li JS, Schiffrin EL. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation. 1999;100:2267-2275.
30. Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T, Igarashi A, Takigawa M, Nakanishi T, Takehara K. Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model. J Cell Physiol. 1999;181:153-159. (Pubitemid 29400382)
31. Viau A, El Karoui K, Laouari D, Burtin M, Nguyen C, Mori K, Pillebout E, Berger T, Mak TW, Knebelmann B, Friedlander G, Barasch J, Terzi F. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J Clin Invest. 2010;120:4065-4076.